↓ Skip to main content

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients…

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
40 Mendeley